New and Noteworthy

Itzhak Kronzon and Paul Tunick review the evolving concept of aortic atherosclerotic disease and stroke.

Circulation 2006 114(1):63-75.
Aortic atherosclerotic disease and stroke
Kronzon I, Tunick PA

Fred Feit and ACUITY investigators examine bivalirudin in patients with acute coronary syndromes

NEJM 355(21):2203-2216.
Bivalirudin for patients with acute coronary syndromes
Stone GW, McLaurin BT, Cox DA, Bertrand ME, Lincoff, AM, Moses JW, White HD, Pocock Sj, Ware JH, Feit F, et al.

Edward Fisher and colleagues develop novel HDL-based nanoparticle to image atherosclerotic plaques by MRI

Nano Lett.  2006 6(10):2220-2224.

Properties of a versatile nanoparticle platform contrast agent to image and characterize atherosclerotic plaques by magnetic resonance imaging.

Frias JC, Ma Y, Williams KJ, Fayad ZA, Fisher EA.

Judith Hochman and colleagues define optimum therapy for heart attack complicated by cardiogenic shock

JAMA. 2006 Jun 7;295(21):2511-5.

Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction

Harmony Reynolds receives DDCF Clinical Scientist Development Award

Dr. Reynolds, an Assistant Professor of Medicine, is one of 23 junior physician-scientists who have been selected to receive a prestigious Clinical Scientist Development Award from the Doris Duke Charitable Foundation.  Dr. Reynolds will lead a study of Women with Acute Coronary Syndromes and Non-Obstructive Coronary Artery Disease (the SWAN study).  See DDCF Press Release for additional details.

Edward Fisher and colleagues discover role of chemokine receptor CCR7 in regression of atherosclerosis

Proc Natl Acad Sci U S A. 2006 Mar 7;103(10):3781-6. Epub 2006 Mar 1

Gene expression changes in foam cells and the role of chemokine receptor CCR7 during atherosclerosis regression in ApoE-deficient mice

Trogan E, Feig JE, Dogan S, Rothblat GH, Angeli V, Tacke F, Randolph GJ, Fisher EA.

Resources